Results 231 to 240 of about 542,074 (310)
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Patients and treatments in a neuropalliative outpatient clinic: an analysis of clinical routine data from five years of care. [PDF]
Grimm T +5 more
europepmc +1 more source
This systematic literature review aimed to identify and characterize existing interventions designed to empower citizens to spontaneously report adverse drug reactions (ADRs) and to determine which interventions have been shown to be the most effective internationally. The research question was structured using the PICO framework.
Margarida Perdigão +3 more
wiley +1 more source
Sustainability and minimization of carbon footprint in ophthalmology: what can we change in the outpatient clinic routine? [PDF]
Akgun Z, Palamar M.
europepmc +1 more source
Abstract Aim The French authorities mandated the use of secure prescriptions for pregabalin on May 2021. This study aimed to evaluate the impact of this measure on pregabalin use and misuse in Nouvelle‐Aquitaine, a southwestern French region with around six million inhabitants.
Maika Munech‐Herran +5 more
wiley +1 more source
Evaluation of psychiatric conditions in asymptomatic outpatient clinic patients. [PDF]
Erinc O, Yesilyurt S.
europepmc +1 more source
Aims Voriconazole is commonly used to prevent fungal infections after haematopoietic stem cell transplantation (HSCT). Although its metabolism is influenced by CYP2C19 genetics and inflammation, their combined effect is rarely considered in clinical practice, and integrated analyses remain limited.
Sylvia D. Klomp +6 more
wiley +1 more source
Medication reconciliation and drug interactions in adult cystic fibrosis patients attending an outpatient clinic: A Cross-sectional study. [PDF]
de Jesus Camara R +4 more
europepmc +1 more source
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman +9 more
wiley +1 more source
Survey on the disease spectrum of Chinese patients at the outpatient clinic of the 30th Chinese medical aid team in Guinea. [PDF]
Li W +17 more
europepmc +1 more source

